Table 1

Overall baseline characteristics and outcome measures of the study population

CharacteristicN (%) or median (IQR)
Age (years)67 (55–76)
Gender, male145 (46.8)
Hypertension246 (79.4)
Dyslipidaemia116 (37.4)
Atrial fibrillation94 (30.3)
Diabetes82 (26.5)
Smoking63 (20.3)
Glucose122 (103–151)
Baseline SBP150 (130–175)
Baseline NIHSS17 (14–21)
e-ASPECTS8 (7-9)
CTP core (CBF <30%)6.6 (0–23.75)
IV t-PA47 (15.2)
Occlusion site
 ACA2 (0.6%)
 Extracranial ICA12 (3.9%)
 Intracranial ICA51 (16.5%)
 MCA-M1154 (49.7%)
 MCA-M245 (14.5%)
 MCA-M37 (2.3%)
 Tandem occlusion*39 (12.6%)
Time from LWN to arterial puncture (min)645(478–900)
mTICI (2b-3)300 (96.8)
Any PH31 (10)
90-day mRS 0–2†102 (40.2)
90-day mortality†63 (24.8)
  • *Intracranial occlusion site: ICA-T: 15/39 (38.5%), MCA-M1: 19/39 (48.7%) and MCA-M2: 5/39 (12.8%).

  • †n=254.

  • ACA, anterior cerebral artery; ASPECTS, Alberta Stroke Program Early CT Score; CBF, cerebral blood flow; CTP, CT perfusion; ICA, internal carotid artery; LKN, Last Known Normal; NIHSS, baseline National Institute of Health Stroke Scale; PH, parenchymal haematoma; SBP, systolic blood pressure.